BioNexus Gene Lab Corp (NASDAQ:BGLC) currently has a daily average trading volume of 205.53K but it saw 950761 shares traded in last market. With a market cap of 10.61M USD, the company’s current market price of $0.60 came rising about 20.10 while comparing to the previous closing price of $0.50. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.88 and as low as $0.31.
Taking a look at 20-day trading activity of BioNexus Gene Lab Corp (BGLC) gives us an average price of $0.5346, while its current price level is -96.64% below from 52-week high level whereas it is 93.71% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5914 while that of 200 days or SMA-200 reads an average of $0.6864. A closer look into the stock’s movement over the week reveals that its volatility is standing at 25.82% during that period while stretching the period over a month that decreases to 11.44%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 58.09 which implies that the stock is in neutral territory.
Over the week, BGLC’s stock price is moving 37.86% up while it is 0.38% when we observe its performance for the past one month. Year-to-date it is 13.30% up and over the past year, the stock is showing a downside performance of -83.86%.
Currently, BioNexus Gene Lab Corp’s total number of outstanding shares is 17.67M. Company’s return on investment (ROI) stands at -28.24% and return on equity (ROE) at -33.50%. Stock’s beta reads 1.83. Stock has a price to book (P/B) ratio of 1.14 while price to sale or P/S ratio amounts to 1.08. Its return on asset (ROA) is -27.53% on average.
